Antiviral agents for the treatment of COVID-19: Progress and challenges

The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in COVID-19 patients, especially when administered early after diagnosis. Here, we discuss the successes and challenges of COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Manmeet, de Wit, Emmie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831133/
https://www.ncbi.nlm.nih.gov/pubmed/35474740
http://dx.doi.org/10.1016/j.xcrm.2022.100549
Descripción
Sumario:The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in COVID-19 patients, especially when administered early after diagnosis. Here, we discuss the successes and challenges of COVID-19 antiviral therapies and lessons for future pandemics.

Ejemplares similares